As of 1:00pm ET
| -0.08 / -2.16%|
The 3 analysts offering 12-month price forecasts for Lipocine Inc have a median target of 15.00, with a high estimate of 38.00 and a low estimate of 11.00. The median estimate represents a +313.22% increase from the last price of 3.63.
The current consensus among 3 polled investment analysts is to Buy stock in Lipocine Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.